Navigation Links
TetraLogic Pharmaceuticals Announces New Executives
Date:8/19/2013

MALVERN, Pa., Aug. 19, 2013 /PRNewswire/ -- TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule SMAC mimetic drugs to treat cancer, today announced the appointment of a new senior executive leadership team with the goal of accelerating the development of the company and its lead product candidate birinapant. The new TetraLogic senior executives are J. Kevin Buchi, President and Chief Executive Officer, Pete A. Meyers, Chief Financial Officer, and Lesley Russell, MBChB, MRCP, Chief Operating Officer.  John M. Gill, the departing President, Chief Executive Officer and Co-founder of TetraLogic, will continue to serve on the company's Board of Directors.

"I am pleased to hand over the reins to Kevin who is a highly regarded leader within our industry," stated Mr. Gill. "Together with Pete Meyers and Lesley Russell, this team represents the ideal complement to the existing team at TetraLogic, bringing the expertise and experience we need to maximize the value of our lead SMAC mimetic drug candidate birinapant, grow the company, and realize the full economic potential of our commercial opportunities for our shareholders."

"I am honored to be chosen to lead TetraLogic at this very exciting time for the company," stated Mr. Buchi. "With a strong team and clear leadership position in SMAC mimetics, we have a tremendous opportunity to continue the momentum established for birinapant as a potential treatment for both solid tumors and hematological malignancies. Having spent most of my career in the biotech industry, I have a strong sense of the opportunities for success at TetraLogic and look forward to leading the company into what promises to be an exciting future."

Mr. Buchi was most recently Corporate Vice Presi
'/>"/>

SOURCE TetraLogic Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , August 27, 2014 ... Equipment Market By Products (Dental Radiology, CAD/CAM, Dental Chairs, Dental ... published by MarketsandMarkets, the global Dental Equipment Market is ... $5,416.3 million in 2014, growing at a CAGR ... Browse 95 market data tables and 61 figures ...
(Date:8/27/2014)... , Aug. 27, 2014 Pulse Systems, ... (EHR) , Practice Management , and Revenue Cycle ... known business practices performed by some RCM vendors, at UBM ... PA on September 19-20, 2014.  ... will return in September with a new session encouraging practices ...
(Date:8/27/2014)... HONG KONG , Aug. 27, 2014 /PRNewswire/ ... ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical ... franchise in China,s prescription ... of the Company and its subsidiaries (collectively the ... 2014 (the "Period"). Financial HighlightsFor the ...
Breaking Medicine Technology:Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 2Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 3Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 4Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7
... (Nasdaq: STXS ) announced today financial results for ... with the preliminary results reported on October 13, 2010. Third ... and reductions in both operating loss and net loss. ... compared to $13.3 million in the third quarter 2009. As ...
... Quality Forum (NQF) announces the election of leadership ... NQF is a unique, multi-stakeholder, nonprofit ... healthcare by setting national priorities and goals for ... and publicly reporting on performance, and promoting the ...
Cached Medicine Technology:Stereotaxis Reports Third Quarter Financial Results 2Stereotaxis Reports Third Quarter Financial Results 3Stereotaxis Reports Third Quarter Financial Results 4Stereotaxis Reports Third Quarter Financial Results 5Stereotaxis Reports Third Quarter Financial Results 6Stereotaxis Reports Third Quarter Financial Results 7National Quality Forum Members Elect New Council Leaders 2
(Date:8/27/2014)... Aug. 26, 2014 (HealthDay News) -- Health care workers ... gear to keep them safe from being infected with ... study shows. While the study was conducted before ... spring, its findings are confirmed in statistics released Monday ... health agency reported that an "unprecedented" number of health ...
(Date:8/27/2014)... and a new UCLA study has shown this is definitely ... decisions about how to treat their prostate cancer. , UCLA ... disease have a much more difficult time making treatment decisions, ... quality of their care and their long-term outcomes. , The ... can use the findings to target men less likely to ...
(Date:8/27/2014)... CIC microGUNE, the Co-operative Research Centre into ... seeks to generate innovative solutions based on ... mobility industry and life sciences, among others. ... Tecnun are collaborating with CIC microGUNE on ... funded by the Etortek 2013-2014 programme of ...
(Date:8/27/2014)... a week of tomatoes have an 18 per cent ... , With 35,000 new cases every year in the ... second most common cancer in men worldwide. , Rates ... is linked to a Westernised diet and lifestyle. , ... risk of prostate cancer, researchers at the Universities of ...
(Date:8/27/2014)... news release is available in German . ... for medical agents to treat metastatic tumors. In case of ... that is often detected late, 95% of the patients die ... develops tumor therapeutic agents that might reduce this mortality rate. ... now received a total of EUR 5 million from investors. ...
Breaking Medicine News(10 mins):Health News:Lack of Protective Gear Leaves Medics at Risk in Ebola Outbreak: Study 2Health News:Lack of Protective Gear Leaves Medics at Risk in Ebola Outbreak: Study 3Health News:Men who are uneducated about their prostate cancer have difficulty making good treatment choices 2Health News:Men who are uneducated about their prostate cancer have difficulty making good treatment choices 3Health News:Microtechnologies for driving forward mobility and human health 2Health News:Fighting prostate cancer with a tomato-rich diet 2Health News:Preclinical development of tumor therapeutic agent starts 2
... VP of Products and Marketing Will Address Growing Healthcare Trends ... Tools ... Michael Flanagan, VP of products,and marketing for Portico Systems, the ... Optimizing Provider,Network Management" at the Institute for International Research,s,conference in ...
... Barcelona, Spain: Recent political decisions have had serious ... at ECCO 14, the European Cancer Conference, today ... the Federation of European Cancer Societies (FECS) said ... take an active role in engaging with policymakers ...
... spontaneous quit attempts can be successful, PITTSBURGH, ... quit attempt may not be the path to ... for a quit attempt, a new national,survey conducted ... quitting may not require an advance plan.(1) In ...
... of Diabetic Neuropathy Market Will Be Driven by Launches, of ... ... Resources, WALTHAM, Mass., Sept. ... firms for pharmaceutical and,healthcare issues, finds that by 2016 Genentech/Roche,s Lucentis ...
... the Cure with its ... Emmy Award-winning journalist and TV personality Cristina ... Munchkin, Inc. -- maker of award-winning infant and ... again reminding women everywhere "Don,t Duck a ...
... to encourage an individual to get screened for ... according to researchers at Jefferson Medical College in ... interventions that guide recipients through the screening process ... primary care practices. , Ronald Myers, Ph.D., professor ...
Cached Medicine News:Health News:Portico Systems to Share Provider Network Management Best Practices at Institute for International Research 2Health News:Political decisions harming cancer treatment in Europe 2Health News:Photos: New Survey Shows Many Successful Quit Smoking Attempts Made Without Advance Planning 2Health News:Photos: New Survey Shows Many Successful Quit Smoking Attempts Made Without Advance Planning 3Health News:Photos: New Survey Shows Many Successful Quit Smoking Attempts Made Without Advance Planning 4Health News:Genentech/Roche's Lucentis and Eli Lilly's Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets 2Health News:Cristina Saralegui Joins Celebrities Including Matthew McConaughey, Courteney Cox and Mariska Hargitay to Raise Money for Breast Cancer Research 2Health News:Jefferson researchers find personalized interventions key to improving colon cancer screening rates 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: